US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

BioStem Technologies, Inc.

5.72

-0.0850-1.47%

Volume:44.40K

Turnover:250.13K

Market Cap:95.76M

PE:6.49

High:5.89

Open:5.80

Low:5.52

Close:5.80

52wk High:15.74

52wk Low:3.09

Shares:16.76M

Float Shares:16.34M

Volume Ratio:0.45

T/O Rate:0.27%

Dividend:- -

Dividend Rate:- -

EPS(TTM):0.8800

EPS(LYR):1.47

ROE:55.46%

ROA:11.47%

PB:1.91

PE(LYR):3.89

Loading ...

Overview Company News Filings

BioStem’s Diabetic Foot Ulcer Trial Reaches Completion: What Investors Should Watch Next

Biotissue Holdings, Inc Strengthens Strategic Focus on Ocular Innovation With Sale of Surgical and Wound Care Business to Biostem Technologies

THOMSON REUTERS

BioStem Technologies (OTCPK:BSEM) Valuation Check After Recent Share Price Rebound

Simply Wall St.

Press Release: BioStem Technologies Announces Filing of Restated Financial Statements

BioStem Q3 revenue falls 43%, net income sinks

Biostem Technologies, Inc. Q3 EPS USD 0.03

THOMSON REUTERS

Biostem Technologies Reports Positive Top-Line Clinical Results Demonstrating Superior Outcomes With Bioretain® Allograft in Diabetic Foot Ulcers

THOMSON REUTERS

Biostem Technologies Expands Partnership With the Florida Panthers as a Sponsor for the 13TH Season of the “Heroes Among US” Program

THOMSON REUTERS

Biostem Technologies Announces Insider Share Purchase by Chairman and Chief Executive Officer

THOMSON REUTERS

Biostem Technologies, Inc. Q2 EPS USD -0.03

THOMSON REUTERS

Biostem Technologies Appoints Brandon Poe as Chief Financial Officer

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/BSEM/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BSEM","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BSEM\",,,,,undefined,":{"symbol":"BSEM","market":"US","secType":"STK","nameCN":"BioStem Technologies, Inc.","latestPrice":5.715,"timestamp":1771361783238,"preClose":5.8,"halted":0,"volume":44404,"delay":15,"changeRate":-0.014655172413793098,"floatShares":16338436,"shares":16756386,"eps":0.88,"marketStatus":"Post-Mkt","change":-0.085,"latestTime":"02-17 15:56:23 EST Delay","open":5.8,"high":5.89,"low":5.52,"amount":250134.58300000007,"amplitude":0.063793,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":0.88,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1771376400000},"marketStatusCode":4,"adr":0,"adrRate":0,"exchange":"PINK","adjPreClose":5.8,"volumeRatio":0.448327},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BSEM\",,,,,undefined,":{"symbol":"BSEM","floatShares":16338436,"roa":"11.47%","roe":"55.46%","lyrEps":1.469999,"volumeRatio":0.448327,"shares":16756386,"dividePrice":0,"high":5.89,"amplitude":0.063793,"preClose":5.8,"low":5.52,"week52Low":3.0932,"pbRate":"1.91","psRate":"0.33","week52High":15.74,"institutionHeld":0,"latestPrice":5.715,"eps":0.88,"divideRate":0,"volume":44404,"delay":15,"ttmEps":0.88,"open":5.8,"prevYearClose":3.81,"prevWeekClose":5.8,"prevMonthClose":6.172,"prevQuarterClose":3.81,"fiveDayClose":6.74,"twentyDayClose":4.2,"sixtyDayClose":3.326},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BSEM\",params:#limit:5,,,undefined,":[{"date":"2025-11-13","symbol":"BSEM","type":"earning","reportTimeType":"","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1763024400000,"name":null,"time":"","dateTimestamp":1763010000000,"actualEps":null},{"date":"2025-08-14","symbol":"BSEM","type":"earning","reportTimeType":"","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1755158400000,"name":null,"time":"","dateTimestamp":1755144000000,"actualEps":null},{"date":"2025-05-12","symbol":"BSEM","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1747080000000,"name":null,"time":"Post Market","dateTimestamp":1747022400000,"actualEps":null},{"date":"2025-04-14","symbol":"BSEM","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1744660800000,"name":null,"time":"Post Market","dateTimestamp":1744603200000,"actualEps":null},{"date":"2024-11-12","symbol":"BSEM","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1731445200000,"name":null,"time":"Post Market","dateTimestamp":1731387600000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BSEM\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BSEM\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BSEM\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2605141404","title":"BioStem’s Diabetic Foot Ulcer Trial Reaches Completion: What Investors Should Watch Next","url":"https://stock-news.laohu8.com/highlight/detail?id=2605141404","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605141404?lang=en_us&edition=fundamental","pubTime":"2026-01-24 00:30","pubTimestamp":1769185824,"startTime":"0","endTime":"0","summary":"BioStem Technologies ($BSEM) announced an update on their ongoing clinical study. BioStem Technologies (BSEM) has reported an update on its prospec...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/biostems-diabetic-foot-ulcer-trial-reaches-completion-what-investors-should-watch-next?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/biostems-diabetic-foot-ulcer-trial-reaches-completion-what-investors-should-watch-next?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BSEM","BK4211","BK4007","ISBC"],"gpt_icon":0},{"id":"2605186439","title":"Biotissue Holdings, Inc Strengthens Strategic Focus on Ocular Innovation With Sale of Surgical and Wound Care Business to Biostem Technologies","url":"https://stock-news.laohu8.com/highlight/detail?id=2605186439","media":"THOMSON REUTERS","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605186439?lang=en_us&edition=fundamental","pubTime":"2026-01-22 07:00","pubTimestamp":1769036400,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260121:nTUA24DV69:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BSEM","BK4007"],"gpt_icon":0},{"id":"2602953434","title":"BioStem Technologies (OTCPK:BSEM) Valuation Check After Recent Share Price Rebound","url":"https://stock-news.laohu8.com/highlight/detail?id=2602953434","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602953434?lang=en_us&edition=fundamental","pubTime":"2026-01-11 07:23","pubTimestamp":1768087436,"startTime":"0","endTime":"0","summary":"BioStem Technologies: Recent Moves and Context for Investors\nBioStem Technologies (BSEM) has drawn fresh investor attention after recent trading, with the stock closing at $5.00 and showing mixed performance across the past week, month, and past 3 months.\nSee our latest analysis for BioStem Technologies.\nThat sharp 17.65% 1 day share price return, on top of a 27.91% year to date share price return, contrasts with a 1 year total shareholder return of a 66.67% decline. As a result, recent...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/otc-bsem/biostem-technologies/news/biostem-technologies-otcpkbsem-valuation-check-after-recent","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/otc-bsem/biostem-technologies/news/biostem-technologies-otcpkbsem-valuation-check-after-recent","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BSEM","DCF","BK4007"],"gpt_icon":0},{"id":"2583517985","title":"Press Release: BioStem Technologies Announces Filing of Restated Financial Statements","url":"https://stock-news.laohu8.com/highlight/detail?id=2583517985","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583517985?lang=en_us&edition=fundamental","pubTime":"2025-11-14 05:42","pubTimestamp":1763070120,"startTime":"0","endTime":"0","summary":"POMPANO BEACH, Fla., Nov. 13, 2025  -- BioStem Technologies, Inc. , a leading MedTech company focused on the development, manufacturing, and commercialization of placental-derived products for advanced wound care, today announced the filing of its restated interim financial statements for the periods from Q1 2024 through Q2 2025 as well as its restated annual financial statements for 2023 and 2024.\"Completing our restated financial statements is a significant milestone for the Company,\" said Brandon Poe, CFO of BioStem. \"This restatement was the culmination of a comprehensive review of the applicable US GAAP revenue recognition guidance in consultation with our external technical accounting advisors, and best accounts for our distribution agreement with Venture Medical. With this process behind us, we are ready to move forward with our independent audit and subsequent uplist process.\". The Company's restated financial statements adjust how it accounts for and reports the bona fide serv","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","SG9999008742.SGD","TM","SG9999000475.SGD","BSEM","BK4077","SG9999004360.SGD","BK4534","TWTR","BK4508","SG9999001135.SGD","R","BK4585","BK4022","V03.SI","SG9999001846.SGD","BK4604","BK4579","BK4232","BK4588","SG9999006266.SGD","BK4099","BK4516","BK6515","BK4555","03160","BK6062"],"gpt_icon":0},{"id":"2583514041","title":"BioStem Q3 revenue falls 43%, net income sinks","url":"https://stock-news.laohu8.com/highlight/detail?id=2583514041","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583514041?lang=en_us&edition=fundamental","pubTime":"2025-11-14 05:18","pubTimestamp":1763068712,"startTime":"0","endTime":"0","summary":"BioStem Q3 revenue falls 43%, net income sinksOverviewBioStem Q3 2025 revenue fell 43% yr/yrNet income for Q3 2025 was $0.8 mln compared to $6.8 mln a year earlierCompany's gross profit margin improve","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251113:nL1N3WP16Y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BSEM","BK4007"],"gpt_icon":0},{"id":"2583187511","title":"Biostem Technologies, Inc. Q3 EPS USD 0.03","url":"https://stock-news.laohu8.com/highlight/detail?id=2583187511","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583187511?lang=en_us&edition=fundamental","pubTime":"2025-11-14 05:02","pubTimestamp":1763067721,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251113:nPLXC53652:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BSEM","BK4007"],"gpt_icon":0},{"id":"2579046847","title":"Biostem Technologies Reports Positive Top-Line Clinical Results Demonstrating Superior Outcomes With Bioretain® Allograft in Diabetic Foot Ulcers","url":"https://stock-news.laohu8.com/highlight/detail?id=2579046847","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579046847?lang=en_us&edition=fundamental","pubTime":"2025-10-31 19:00","pubTimestamp":1761908402,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251031:nTUA2FT9FC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BSEM","BK4007"],"gpt_icon":0},{"id":"2572546750","title":"Biostem Technologies Expands Partnership With the Florida Panthers as a Sponsor for the 13TH Season of the “Heroes Among US” Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2572546750","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572546750?lang=en_us&edition=fundamental","pubTime":"2025-10-03 00:00","pubTimestamp":1759420800,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251002:nTUA9VY8FS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BSEM","BK4007"],"gpt_icon":0},{"id":"2561461578","title":"Biostem Technologies Announces Insider Share Purchase by Chairman and Chief Executive Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2561461578","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561461578?lang=en_us&edition=fundamental","pubTime":"2025-08-21 19:00","pubTimestamp":1755774001,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250821:nTUA44FGFF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","BSEM"],"gpt_icon":0},{"id":"2559096192","title":"Biostem Technologies, Inc. Q2 EPS USD -0.03","url":"https://stock-news.laohu8.com/highlight/detail?id=2559096192","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559096192?lang=en_us&edition=fundamental","pubTime":"2025-08-15 04:06","pubTimestamp":1755201960,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250814:nPLX100977:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","BSEM"],"gpt_icon":0},{"id":"2559961569","title":"Biostem Technologies Appoints Brandon Poe as Chief Financial Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2559961569","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559961569?lang=en_us&edition=fundamental","pubTime":"2025-08-15 04:01","pubTimestamp":1755201704,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250814:nTUA1S5NLM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ILMN","BK4548","BSEM","BK4588","BK4534","BK4007","BK4535","BK4585","BK4121"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":11,"code":"91000000","status":"200"}]}}